INDRAPRASTHA MEDICAL share price has zoomed 5% and is presently trading at Rs 392.0.
Meanwhile, the BSE HEALTHCARE index is at 42,157.2 (up 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are FORTIS HEALTHCARE (up 4.3%) and POLY MEDICURE (up 1.5%).
ERIS LIFESCIENCES (down 2.1%) and Cadila Healthcare (down 1.9%) are among the top losers today.
Over the last one year, INDRAPRASTHA MEDICAL has moved up from Rs 159.5 to Rs 392.0, registering a gain of Rs 232.5 (up 145.7%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,021.8 to 42,157.2, registering a gain of 50.4% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.4%), Glenmark Pharma (up 117.2%) and GSK Pharma (up 110.5%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 81,123.0 (up 0.1%).
The top gainers among the BSE Sensex today are Tata Motors (up 1.7%) and M&M (up 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,842.6 (up 0.1%). Bajaj Auto and Tata Motors are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,216.1 to 81,123.0, registering a gain of 15,906.9 points (up 24.4%).
INDRAPRASTHA MEDICAL net profit grew 46.8% YoY to Rs 448 million for the quarter ended June 2024, compared to a profit of Rs 305 million a year ago. Net sales rose 13.5% to Rs 3,479 million during the period as against Rs 3,065 million in April-June 2023.
For the year ended March 2023, INDRAPRASTHA MEDICAL reported 47.0% increase in net profit to Rs 862 million compared to net profit of Rs 586 million during FY22. Revenue of the company grew 23.7% to Rs 10,987 million during FY23.
The current Price to earnings ratio of INDRAPRASTHA MEDICAL, based on rolling 12 month earnings, stands at 26.0.
Equitymaster requests your view! Post a comment on "INDRAPRASTHA MEDICAL Gains 5%; BSE HEALTHCARE Index Up 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!